Duration of Anti-PD-1 Therapy in Metastatic Melanoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

614

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Unresectable/Metastatic Melanoma
Interventions
DRUG

Intermittent PD-1 inhibitor therapy

DRUG

Continuous PD-1 inhibitor therapy

Trial Locations (31)

2145

RECRUITING

Westmead Hospital, Westmead

2298

RECRUITING

Calvary Mater Newcastle Hospital, Waratah

2450

RECRUITING

Coffs Habour Health Campus - NCCI, Coffs Harbour

2650

NOT_YET_RECRUITING

Riverina Cancer Care Centre Wagga Wagga, Wagga Wagga

3004

RECRUITING

Alfred Hospital, Melbourne

3168

RECRUITING

Monash Medical Centre, Clayton

3500

RECRUITING

Mildura Base Public Hospital, Victoria

4029

RECRUITING

Royal Brisbane and Womens Hospital, Herston

4215

RECRUITING

Gold Coast University Hospital, Southport

4575

RECRUITING

Sunshine Coast University Hospital, Birtinya

4870

RECRUITING

Cairns Hospital, Cairns

5011

RECRUITING

The Queen Elizabeth Hospital, Woodville

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

V3V 1Z2

RECRUITING

BCCA - Surrey, Surrey

V5Z 4E6

RECRUITING

BCCA - Vancouver, Vancouver

V8R 6V5

RECRUITING

BCCA - Victoria, Victoria

E3B 5N5

RECRUITING

Horizon Health Network, Fredericton

L4M 6M2

RECRUITING

Royal Victoria Regional Health Centre, Barrie

P3E 5J1

RECRUITING

Health Sciences North, Greater Sudbury

L8V 5C2

RECRUITING

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 2V7

RECRUITING

Kingston Health Sciences Centre, Kingston

N2G 1G3

RECRUITING

Waterloo Regional Health Network (WRHN), Kitchener

N6A 5W9

RECRUITING

London Health Sciences Centre Research Inc., London

L5M 2N1

RECRUITING

Trillium Health Partners - Credit Valley Hospital, Mississauga

L1G 2B9

RECRUITING

Lakeridge Health Oshawa, Oshawa

K1H 8L6

RECRUITING

Ottawa Hospital Research Institute, Ottawa

M4N 3M5

RECRUITING

Odette Cancer Centre, Toronto

M5G 2M9

RECRUITING

University Health Network, Toronto

H4A 3J1

RECRUITING

The Research Institute of the McGill University, Montreal

S4T 7T1

RECRUITING

Allan Blair Cancer Centre, Regina

S7N 4H4

RECRUITING

Saskatoon Cancer Centre, Saskatoon

All Listed Sponsors
collaborator

Melanoma and Skin Cancer Trials Limited

OTHER

lead

Canadian Cancer Trials Group

NETWORK

NCT02821013 - Duration of Anti-PD-1 Therapy in Metastatic Melanoma | Biotech Hunter | Biotech Hunter